17 Aug 2026Open access
Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory AgentsPublisher siteDrug Development Research, Neuroscience and Neuropharmacology Research
Active, last published 2026
In synthesis and biological activity
Mohamed K.
Elgohary
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Claim Your Profile13
H-index
329
Citations
Mohamed has not officially claimed their profile. If you are Mohamed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohamed K. Elgohary is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mohamed's work has been cited 329 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×15Inflammatory mediators and NSAID effects×6Cancer Mechanisms and Therapy×5Synthesis and Characterization of Heterocyclic Compounds×5Computational Drug Discovery Methods×4
04 · Where I am
Affiliations
Affiliation on published researchEgyptian Russian University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
16 works17 Dec 20255cites
Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ <i>b</i> ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLCPublisher siteDrug Development Research, Click Chemistry and Applications
9 Oct 2025
Harnessing benzofuran scaffolds: A journey through design, synthesis, and biological discovery toward safer anti-diabetic and anti-oxidant candidatesPublisher siteEuropean Journal of Medicinal Chemistry, Click Chemistry and Applications
7 May 20257cites
Development of Benzothiazole-grafted Pyrazolo[1,5-a]pyrimidines as new CDK2 inhibitors and anti-prostate cancer agentsPublisher siteBioorganic Chemistry, Synthesis and Biological Evaluation
13 Mar 2025Open access12cites
Design, synthesis and biological evaluation of pyrazolo[3,4- <i>b</i> ]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivityPublisher siteJournal of Biomolecular Structure and Dynamics, Cancer Mechanisms and Therapy
5 Feb 202513cites
Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profilesPublisher siteBioorganic Chemistry, Lung Cancer Treatments and Mutations
1 Jan 2025Open access1cites
Discovery and characterization of phenoxyacetic acid derivatives as potential antiepileptic agentsPublisher siteRSC Advances, Epilepsy research and treatment
28 Dec 202415cites
Sulfonamide-Pyrazole derivatives as next-generation Cyclooxygenase-2 enzyme inhibitors: From molecular design to in vivo efficacyPublisher siteInternational Journal of Biological Macromolecules, Inflammatory mediators and NSAID effects
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mohamed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you